The effect of levomepromazine on the healthy and injured developing mouse brain - An

CCK-8, Cell Counting Kit-8 CD-1 mouse HT-22 IQR, interquartile range LMP, levomepromazine Levomepromazine Methotrimeprazine NICU, Neonatal Intensive Care Unit NaCl, sodium chloride Neonatal excitotoxic brain injury PBS, phosphate-buffered saline Phenothiazine Px, postnatal day x TUNEL, terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling bw, body weight i.c., intracranial i.p., intraperitoneal

Journal

IBRO reports
ISSN: 2451-8301
Titre abrégé: IBRO Rep
Pays: England
ID NLM: 101691215

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 25 07 2020
accepted: 15 09 2020
entrez: 7 10 2020
pubmed: 8 10 2020
medline: 8 10 2020
Statut: epublish

Résumé

Levomepromazine (LMP) is a phenothiazine neuroleptic drug with strong analgesic and sedative properties that is increasingly used off-label in pediatrics and is being discussed as an adjunct therapy in neonatal intensive care. Basic research points towards neuroprotective potential of phenothiazines, but LMP's effect on the developing brain is currently unknown. The aim of the present study was to assess LMP as a pharmacologic strategy in established neonatal

Identifiants

pubmed: 33024879
doi: 10.1016/j.ibror.2020.09.003
pii: S2451-8301(20)30041-8
pmc: PMC7527626
doi:

Types de publication

Journal Article

Langues

eng

Pagination

247-257

Informations de copyright

© 2020 The Author(s).

Déclaration de conflit d'intérêts

We declare no conflict of interest.

Références

Lancet Neurol. 2009 Jan;8(1):110-24
pubmed: 19081519
Clin Pharmacol Ther. 1976 Apr;19(4):435-42
pubmed: 1269194
Clin Perinatol. 2014 Dec;41(4):895-924
pubmed: 25459780
Sci Rep. 2017 Aug 7;7(1):7469
pubmed: 28785051
Eur J Med Chem. 2010 Dec;45(12):6152-8
pubmed: 20926162
Naunyn Schmiedebergs Arch Pharmacol. 2012 Oct;385(10):1017-23
pubmed: 22806583
Intensive Care Med. 2012 Jan;38(1):175-6
pubmed: 22109654
J Neuropathol Exp Neurol. 1995 May;54(3):358-70
pubmed: 7745435
Pediatr Res. 2014 May;75(5):584-7
pubmed: 24500615
Brain Res. 1994 Jul 25;652(1):169-73
pubmed: 7953717
N Engl J Med. 1987 Nov 19;317(21):1321-9
pubmed: 3317037
Med Hypotheses. 2013 Mar;80(3):252-8
pubmed: 23265349
J Neural Transm (Vienna). 2006 Mar;113(3):387-97
pubmed: 15997416
Clin Perinatol. 2002 Sep;29(3):357-72
pubmed: 12380463
Neuron. 1990 Dec;5(6):875-80
pubmed: 1980069
J Exp Biol. 2004 Aug;207(Pt 18):3149-54
pubmed: 15299036
J Pediatr Intensive Care. 2014 Jun;3(2):53-57
pubmed: 31214452
J Vet Sci. 2016 Mar;17(1):53-61
pubmed: 27051340
Eur Arch Psychiatry Clin Neurosci. 2006 Aug;256(5):274-80
pubmed: 16788768
Pediatrics. 2009 Mar;123(3):1037-44
pubmed: 19255037
Phytomedicine. 2007 Apr;14(4):250-5
pubmed: 17346956
Neurosci Lett. 2015 Jan 1;584:253-8
pubmed: 25449871
J Neurosci. 2007 Jul 11;27(28):7532-40
pubmed: 17626214
Clin Perinatol. 2009 Mar;36(1):15-26
pubmed: 19161862
BMC Palliat Care. 2013 Jan 19;12:2
pubmed: 23331515
Ment Retard Dev Disabil Res Rev. 2001;7(1):56-64
pubmed: 11241883
Biochem Pharmacol. 2001 Aug 15;62(4):401-5
pubmed: 11448448
Biochem Pharmacol. 1995 Jan 31;49(3):359-65
pubmed: 7857323
Neurotox Res. 2018 Aug;34(2):263-272
pubmed: 29589276
Neurol Res Int. 2012;2012:506320
pubmed: 22363841
Pflugers Arch. 2010 Jul;460(2):525-42
pubmed: 20229265
Lancet. 2017 Dec 17;388(10063):3027-3035
pubmed: 27839855
Mol Neurobiol. 2017 Dec;54(10):8140-8150
pubmed: 27896650
Food Chem Toxicol. 2017 May;103:279-288
pubmed: 28315776
Neuroscience. 2003;121(3):619-28
pubmed: 14568022
Pain. 2003 Sep;105(1-2):27-35
pubmed: 14499417
J Med Chem. 1992 Feb 21;35(4):716-24
pubmed: 1542098
Exp Neurol. 2012 Oct;237(2):388-95
pubmed: 22771763
Anticancer Res. 2017 Nov;37(11):5983-5993
pubmed: 29061777
Acta Psychiatr Scand. 1993 Jun;87(6):380-3
pubmed: 8395131
PLoS One. 2012;7(10):e48279
pubmed: 23118969
J Palliat Care. 2013 Autumn;29(3):178-85
pubmed: 24380217
Z Naturforsch C J Biosci. 2002 Nov-Dec;57(11-12):1066-71
pubmed: 12562096
Brain Res. 2016 Mar 1;1634:94-103
pubmed: 26772988
Front Neurol. 2014 Dec 04;5:258
pubmed: 25538677
Curr Opin Neurol. 2002 Apr;15(2):151-7
pubmed: 11923628

Auteurs

Anna Posod (A)

Pediatrics II (Neonatology), Department of Pediatrics, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.

Ira Winkler (I)

Pediatrics II (Neonatology), Department of Pediatrics, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.

Karina Wegleiter (K)

Pediatrics II (Neonatology), Department of Pediatrics, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.

Eva Huber (E)

Pediatrics II (Neonatology), Department of Pediatrics, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.

Martina Urbanek (M)

Pediatrics II (Neonatology), Department of Pediatrics, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.

Ursula Kiechl-Kohlendorfer (U)

Pediatrics II (Neonatology), Department of Pediatrics, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.

Elke Griesmaier (E)

Pediatrics II (Neonatology), Department of Pediatrics, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.

Classifications MeSH